Cargando…
Bariatric Surgery: Targeting pancreatic β cells to treat type II diabetes
Pancreatic β-cell function impairment and insulin resistance are central to the development of obesity-related type 2 diabetes mellitus (T2DM). Bariatric surgery (BS) is a practical treatment approach to treat morbid obesity and achieve lasting T2DM remission. Traditionally, sustained postoperative...
Autores principales: | Liu, Tiantong, Zou, Xi, Ruze, Rexiati, Xu, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975540/ https://www.ncbi.nlm.nih.gov/pubmed/36875493 http://dx.doi.org/10.3389/fendo.2023.1031610 |
Ejemplares similares
-
Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments
por: Ruze, Rexiati, et al.
Publicado: (2023) -
Bariatric Surgery and Type 1 Diabetes: Unanswered Questions
por: Korakas, Emmanouil, et al.
Publicado: (2020) -
Diabetic Ketoacidosis Post Bariatric Surgery
por: Rizo, Ivania M., et al.
Publicado: (2019) -
Lipid metabolism in pancreatic cancer: emerging roles and potential targets
por: Yin, Xinpeng, et al.
Publicado: (2022) -
The Impact of Bariatric Surgery on Type 2 Diabetes Mellitus and the Management of Hypoglycemic Events
por: Kassem, Mahmoud Attia Mohamed, et al.
Publicado: (2017)